Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Semin Oncol

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    October 2016
  1. FEURSTEIN S, Drazer MW, Godley LA
    Genetic predisposition to leukemia and other hematologic malignancies.
    Semin Oncol. 2016;43:598-608.
    PubMed     Text format     Abstract available


    June 2016
  2. GRUNWALD MR, McDonnell MH, Induru R, Gerber JM, et al
    Cutaneous manifestations in leukemia patients.
    Semin Oncol. 2016;43:359-65.
    PubMed     Text format     Abstract available


    April 2016
  3. ROGERS KA, Woyach JA
    Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:300-10.
    PubMed     Text format     Abstract available


  4. FRAIETTA JA, Schwab RD, Maus MV
    Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.
    Semin Oncol. 2016;43:291-9.
    PubMed     Text format     Abstract available


  5. ROBAK T, Blonski JZ, Robak P
    Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:280-90.
    PubMed     Text format     Abstract available


  6. TAM CS, Seymour JF, Roberts AW
    Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:274-9.
    PubMed     Text format     Abstract available


  7. BLACHLY JS, Byrd JC, Grever M
    Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:265-73.
    PubMed     Text format     Abstract available


  8. BROWN JR
    The PI3K pathway: clinical inhibition in chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:260-4.
    PubMed     Text format     Abstract available


  9. MADDOCKS K, Jones JA
    Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:251-9.
    PubMed     Text format     Abstract available


  10. EICHHORST B, Cramer P, Hallek M
    Initial therapy of chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:241-50.
    PubMed     Text format     Abstract available


  11. PARIKH SA, Shanafelt TD
    Prognostic factors and risk stratification in chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:233-40.
    PubMed     Text format     Abstract available


  12. HERMAN SE, Wiestner A
    Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.
    Semin Oncol. 2016;43:222-32.
    PubMed     Text format     Abstract available


  13. AMIN NA, Malek SN
    Gene mutations in chronic lymphocytic leukemia.
    Semin Oncol. 2016;43:215-21.
    PubMed     Text format     Abstract available


  14. VAN ROOSBROECK K, Calin GA
    MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Semin Oncol. 2016;43:209-14.
    PubMed     Text format     Abstract available


  15. WOYACH JA, Johnson AJ, Byrd JC
    Chronic lymphocytic leukemia: recent progress and current challenges.
    Semin Oncol. 2016;43:199-200.
    PubMed     Text format    


  16. ROSSI D, Gaidano G
    Richter syndrome: pathogenesis and management.
    Semin Oncol. 2016;43:311-9.
    PubMed     Text format     Abstract available


  17. SCARFO L, Ghia P
    What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Semin Oncol. 2016;43:201-8.
    PubMed     Text format     Abstract available


    December 2015
  18. YILMAZ M, Jabbour E
    Tyrosine Kinase Inhibitors Early in the Disease Course: Lessons From Chronic Myelogenous Leukemia.
    Semin Oncol. 2015;42:876-86.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: